Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
42.97UNCH (UNCH)
Volume
14,028
Close
42.97quote price arrow up+1.36 (+3.27%)
Volume
511,765
52 week range
25.31 - 141.01

...

Loading . . .
  • Open42.96
  • Day High44.22
  • Day Low41.62
  • Prev Close42.97
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21

Key Stats

  • Market Cap5.499B
  • Shares Out127.98M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change60.46

KEY STATS

  • Open42.96
  • Day High44.22
  • Day Low41.62
  • Prev Close42.97
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21
  • Market Cap5.499B
  • Shares Out127.98M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change60.46

RATIOS/PROFITABILITY

  • EPS (TTM)-3.10
  • P/E (TTM)-13.88
  • Fwd P/E (NTM)-32.75
  • EBITDA (MRQ)-291.538M
  • ROE (MRQ)-52.36%
  • Revenue (MRQ)76.37M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-391.09%
  • Debt To Equity (MRQ)0.13%

EVENTS

  • Earnings Date08/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vir Biotechnology Inc

There is no recent news for this security.

Profile

MORE
Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small interfering ribonucleic acid (siRNA). Its pipeline consists of product candidates targeting hepatitis B virus (HBV), influenza A, human immunodeficiency virus (HIV) and tuberculosis (TB). Its product candidates include VIR-2218...
Vicki Sato Ph.D.
Non-Executive Chairman
George Scangos Ph.D.
President
Howard Horn
Chief Financial Officer
Ann Hanly
Chief Technology Officer
Herbert Virgin M.D., Ph.D.
Executive Vice President
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
TWST
Twist Bioscience Corp
116.74+12.44+11.93%
ALLK
Allakos Inc
100.93+1.78+1.80%
PACB
Pacific Biosciences of California Inc
24.89+0.53+2.18%
TGTX
TG Therapeutics Inc
40.20+0.35+0.88%
KOD
Kodiak Sciences Inc
101.62-0.22-0.22%